Joint Formulary & PAD

Pamidronate disodium - Malignancy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Pamidronate disodium
Indication :
Malignancy
Group Name :
Keywords :
disodium pamidronate, hypercalcaemia of malignancy, bone metastases, prevention of skeletal events
Brand Names Include :
Aredia
Important Information :

Used in

  • hypercalcaemia of malignancy
  • bone metastases
  • prevention of skeletal events
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Pamidronate disodium is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Malignancy.

Committee Recommendations (0)

  • No records returned.